In PrEP: Long-acting antivirals for HIV prevention

被引：1
|
作者：
Sharma, Amit [1 ]
机构：
[1] Ohio State Univ, Dept Microbial Infect & Immun, Dept Vet Biosci, Columbus, OH 43210 USA
来源：
CELL HOST & MICROBE | 2022年 / 30卷 / 02期
基金：
美国国家卫生研究院;
关键词：
PROPHYLAXIS; EFFICACY; MEN;
D O I：
10.1016/j.chom.2022.01.012
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Two recent publications (Vidal et al., 2021; Xue et al., 2022) report highly potent inhibitors as candidates for HIV pre-exposure prophylaxis (PrEP). They provide strong evidence that administration of long-acting capsid or fusion inhibitors as PrEP offers robust protection against simian-human immunodeficiency virus in the rhesus macaque model of HIV infection.
引用
收藏
页码：148 / 150
页数：3
相关论文
共 50 条
  • [41] Estimated long-acting PrEP effectiveness in the HPTN 084 cohort using a model-based HIV incidence in the absence of PrEP
    Moore, M.
    Donnell, D. J.
    Boily, M-C
    Mitchell, K. M.
    Delany-Moretlwe, S.
    Hosseinipour, M.
    Hughes, J. P.
    Hanscom, B.
    Dimitrov, D.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24 : 34 - 34
  • [42] Acceptability of and Preferences for Long-Acting Injectable HIV PrEP and Other PrEP Modalities among Sexual Minority Men in Nigeria, Africa
    Adedotun Ogunbajo
    Alexander C. Tsai
    Phyllis J. Kanki
    Kenneth H. Mayer
    AIDS and Behavior, 2022, 26 : 2363 - 2375
  • [43] Towards long-acting HIV inhibitors
    Sarah Crunkhorn
    Nature Reviews Drug Discovery, 2019, 18 (11) : 826 - 826
  • [44] Long-acting shot against HIV
    Wolf E.
    Noe S.
    MMW - Fortschritte der Medizin, 2017, 159 (Suppl 2) : 36 - 38
  • [45] Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
    Soriano, Vicente
    Moreno-Torres, Victor
    de Mendoza, Carmen
    Fernandez-Montero, Jose V.
    Trevino, Ana
    Corral, Octavio
    de Jesus, Fernando
    Barreiro, Pablo
    AIDS REVIEWS, 2023, 25 (04) : 162 - 172
  • [46] The Potential of Long-Acting, Injectable PrEP, and Impediments to its Uptake
    Miller, Amitai S.
    Krakower, Douglas S.
    Mayer, Kenneth H.
    JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 2023, 100 (01): : 212 - 214
  • [47] The Potential of Long-Acting, Injectable PrEP, and Impediments to its Uptake
    Amitai S. Miller
    Douglas S. Krakower
    Kenneth H. Mayer
    Journal of Urban Health, 2023, 100 : 212 - 214
  • [48] Advancing use of long-acting and extended delivery HIV prevention and treatment regimens
    Delany-Moretlwe, Sinead
    Flexner, Charles
    Bauermeister, Jose A.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2023, 26
  • [49] Regulatory challenges in developing long-acting antiretrovirals for treatment and prevention of HIV infection
    Arya, Vikram
    Au, Stanley
    Belew, Yodit
    Miele, Peter
    Struble, Kimberly
    CURRENT OPINION IN HIV AND AIDS, 2015, 10 (04) : 278 - 281
  • [50] Advances in long-acting injectables, implants, and vaginal rings for contraception and HIV prevention
    Krovi, Sai Archana
    Johnson, Leah M.
    Luecke, Ellen
    Achilles, Sharon L.
    van der Straten, Ariane
    ADVANCED DRUG DELIVERY REVIEWS, 2021, 176
12345